Next Article in Journal
Auricular Non-Epithelial Tumors with Solar Elastosis in Cats: A Possible UV-Induced Pathogenesis
Previous Article in Journal
Impact of Routine Management Procedures on the Welfare of Suckling Piglets
Article

Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome

1
Arrábida Veterinary Hospital—Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, Portugal
2
Superior School of Health, Protection and Animal Welfare, Polytechnic Institute of Lusophony, Campo Grande, 1950-396 Lisboa, Portugal
3
School of Agrarian and Veterinary Sciences, Department of Veterinary Science, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal
4
Faculty of Veterinary Medicine, University of Lisbon, 1300-477 Lisbon, Portugal
5
CIISA—Centro Interdisciplinar-Investigação em Saúde Animal, Faculdade de Medicina Veterinária, Av. Universidade Técnica de Lisboa, 1300-477 Lisbon, Portugal
6
Faculty of Veterinary Medicine, Lusófona University, Campo Grande 376, 1749-024 Lisbon, Portugal
*
Author to whom correspondence should be addressed.
Academic Editor: David J. Argyle
Vet. Sci. 2022, 9(2), 33; https://doi.org/10.3390/vetsci9020033
Received: 24 November 2021 / Revised: 1 January 2022 / Accepted: 14 January 2022 / Published: 18 January 2022
(1) Background: Systemic inflammatory response syndrome (SIRS) can occur due to a large number of traumatic or non-traumatic diseases. Hyperbaric oxygen therapy (HBOT) may be used as a main or adjuvant treatment for inflammation, leading to the main aim of this study, which was to verify the applicability of HBOT as a safe and tolerable tool in SIRS-positive dogs. (2) Methods: This prospective cohort study included 49 dogs who showed two or more parameters of SIRS, divided into the Traumatic Study Group (n = 32) and the Non-Traumatic Study Group (n = 17). All dogs were submitted to HBOT for 60–90 min sessions, with 2.4–2.8 ATA. (3) Results: This study revealed that 73.5% (36/49) of dogs showed improvement, and the minimum number of HBOT sessions was two, with a mean of 12.73. The number of days between diagnosis and the beginning of HBOT showed statistical significance (p = 0.031) relative to the clinical outcome. No dogs showed any major side effects. (4) Conclusions: We concluded that HBOT may be safe and tolerable for SIRS-positive dogs, and that it should be applied as early as possible. View Full-Text
Keywords: SIRS; HBOT; traumatic; dogs; ATA SIRS; HBOT; traumatic; dogs; ATA
Show Figures

Figure 1

MDPI and ACS Style

Gouveia, D.; Chichorro, M.; Cardoso, A.; Carvalho, C.; Silva, C.; Coelho, T.; Dias, I.; Ferreira, A.; Martins, Â. Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome. Vet. Sci. 2022, 9, 33. https://doi.org/10.3390/vetsci9020033

AMA Style

Gouveia D, Chichorro M, Cardoso A, Carvalho C, Silva C, Coelho T, Dias I, Ferreira A, Martins Â. Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome. Veterinary Sciences. 2022; 9(2):33. https://doi.org/10.3390/vetsci9020033

Chicago/Turabian Style

Gouveia, Débora, Mariana Chichorro, Ana Cardoso, Carla Carvalho, Cátia Silva, Tiago Coelho, Isabel Dias, António Ferreira, and Ângela Martins. 2022. "Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome" Veterinary Sciences 9, no. 2: 33. https://doi.org/10.3390/vetsci9020033

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop